Status: Recruiting
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
This project aims to evaluate the efficacy and safety of the combination of glucocorticoids with tocilizumab or tofacitinib, compared to the traditional combination of glucocorticoids with cyclophosphamide in the treatment of vascular Behçet's syndrome.
Participants needed: 81
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Peking Union Medical College HospitalUpdated: Aug 19, 2024Locations: 1
Eligibility criteria
Cardiovascular manifestations that cannot be distinguished from giant cell arter... [+10]